FMA
SPPI

FNY Managed Accounts’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

FNY Managed Accounts’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-763
Closed -$14K – 895
2017
Q4 		$14K Buy
+763
New +$13.8K 0.01% 176

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FNY Managed Accounts's SPPI Position: Q1 2018 in Review

FNY Managed Accounts sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2018, closing a stake of 763 shares — an estimated $14K sold.

FNY Managed Accounts first reported a position in SPPI in Q4 2017 and held it in 1 quarter. The position peaked at $14K in Q4 2017. 161 funds tracked by Wall St. Rank hold SPPI as of Q1 2018.

  • FNY Managed Accounts reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2018 after selling out during the quarter.
  • FNY Managed Accounts sold 763 Spectrum Pharmaceuticals Inc shares in Q1 2018, an estimated $14K.
  • FNY Managed Accounts first reported a position in Spectrum Pharmaceuticals Inc in Q4 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Spectrum Pharmaceuticals Inc position peaked at $14K in Q4 2017.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.